BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 36701848)

  • 1. High expression of LGR6 is a poor prognostic factor in esophageal carcinoma.
    Ehara T; Uehara T; Yoshizawa T; Kinugawa Y; Nakajima T; Kobayashi S; Asaka S; Iwaya M; Nagaya T; Kitazawa M; Ota H; Soejima Y
    Pathol Res Pract; 2023 Feb; 242():154312. PubMed ID: 36701848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LGR6 is a potential diagnostic and prognostic marker for esophageal squamous cell carcinoma.
    Chai T; Shen Z; Zhang Z; Chen S; Gao L; Zhang P; Lin W; Kang M; Lin J
    J Clin Lab Anal; 2020 Apr; 34(4):e23121. PubMed ID: 31917882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HER2 expression and relevant clinicopathological features in esophageal squamous cell carcinoma in a Chinese population.
    Rong L; Wang B; Guo L; Liu X; Wang B; Ying J; Xue L; Lu N
    Diagn Pathol; 2020 Mar; 15(1):27. PubMed ID: 32209107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.
    Cui XB; Zhang SM; Xu YX; Dang HW; Liu CX; Wang LH; Yang L; Hu JM; Liang WH; Jiang JF; Li N; Li Y; Chen YZ; Li F
    J Transl Med; 2016 May; 14(1):137. PubMed ID: 27188458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of ΔNp63 in advanced esophageal squamous cell carcinoma.
    Kumakura Y; Rokudai S; Iijima M; Altan B; Yoshida T; Bao H; Yokobori T; Sakai M; Sohda M; Miyazaki T; Nishiyama M; Kuwano H
    Cancer Sci; 2017 Nov; 108(11):2149-2155. PubMed ID: 28892579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B7H4 is associated with stemness and cancer progression in esophageal squamous cell carcinoma.
    Piao L; Yang Z; Jin J; Ni W; Qi W; Xuan Y
    Hum Pathol; 2018 Oct; 80():152-162. PubMed ID: 29885401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased MET gene copy number negatively affects the survival of esophageal squamous cell carcinoma patients.
    Wang Y; Jiang Z; Xu C; Wang H; Tan L; Su J; Wang X; Jiang D; Hou Y; Song Q
    BMC Cancer; 2019 Mar; 19(1):240. PubMed ID: 30885149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathological and prognostic significance of the expression of ADAM17 mRNA and protein in esophageal squamous cell carcinoma].
    Liu HB; Yang QC; Shen Y; Zhu Y; Zhang XJ; Chen H
    Zhonghua Zhong Liu Za Zhi; 2013 May; 35(5):361-5. PubMed ID: 24054013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of OTX1 promotes tumorigenesis in patients with esophageal squamous cell carcinoma.
    Chai J; Xu T; Yang Y; Yuan Y; Xu J; Liu J; Wang K; Lv Y; Chai J; Kang Y; Chen L; Qin J; Jia Q; Li M
    Pathol Res Pract; 2022 Apr; 232():153841. PubMed ID: 35303522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value and characterization of NTRK1 variation by fluorescence in situ hybridization in esophageal squamous cell carcinoma.
    Yu Z; Wang H; Song Q; Huang J; Xu J; Su J; Wang H; Tan L; Wang X; Jiang Z; Chen W; Jiang D; Hou Y
    J Cancer Res Clin Oncol; 2021 Oct; 147(10):3113-3121. PubMed ID: 33963905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
    Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
    PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SET domain-containing 5 is a potential prognostic biomarker that promotes esophageal squamous cell carcinoma stemness.
    Piao L; Li H; Feng Y; Yang Z; Kim S; Xuan Y
    Exp Cell Res; 2020 Apr; 389(1):111861. PubMed ID: 31981592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of CCND1 amplification/overexpression in smoking patients with esophageal squamous cell carcinoma.
    Jiang D; Song Q; Zhang F; Xu C; Li X; Zeng H; Su J; Huang J; Xu Y; Lu S; Hou Y
    Cancer Genet; 2023 Nov; 278-279():1-8. PubMed ID: 37556965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
    Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
    Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ESM1 Is a Promising Therapeutic Target and Prognostic Indicator for Esophageal Carcinogenesis/Esophageal Squamous Cell Carcinoma.
    Li J; Yang D; Zhang C; Wei S; Zhao R; Dai S; Shan B
    Biomed Res Int; 2022; 2022():5328192. PubMed ID: 35937390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upregulation of the long non-coding RNA BANCR correlates with tumor progression and poor prognosis in esophageal squamous cell carcinoma.
    Liu Z; Yang T; Xu Z; Cao X
    Biomed Pharmacother; 2016 Aug; 82():406-12. PubMed ID: 27470379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-145 expression level in tissue predicts prognosis of patients with esophageal squamous cell carcinoma.
    Jin W; Luo W; Fang W; Wang Y; Wang L; Shen Q; Liu W; Zhang H
    Pathol Res Pract; 2019 Jun; 215(6):152401. PubMed ID: 31014553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor prognostic impact of FGF4 amplification in patients with esophageal squamous cell carcinoma.
    Huang J; Song Q; Wang H; Wang H; Xu C; Wang X; Jiang Z; Wang Y; Xu Y; Su J; Zeng H; Tan L; Zhu H; Jiang D; Hou Y
    Hum Pathol; 2018 Oct; 80():210-218. PubMed ID: 29936056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low expression of PRDM5 predicts poor prognosis of esophageal squamous cell carcinoma.
    Guo J; Yang Q; Wei S; Shao J; Zhao T; Guo L; Liu J; Chen J; Wang G
    BMC Cancer; 2022 Jul; 22(1):745. PubMed ID: 35799142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and functional regulation of stemness gene Lgr5 in esophageal squamous cell carcinoma.
    Lv Z; Yu JJ; Zhang WJ; Xiong L; Wang F; Li LF; Zhou XL; Gao XY; Ding XF; Han L; Cai YF; Ma W; Wang LX
    Oncotarget; 2017 Apr; 8(16):26492-26504. PubMed ID: 28404917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.